CEO & Chairman (born 1965). CEO since 2025, Chairman since 2019. MD, PhD, Associate Professor (Karolinska Institutet). Circa 20 years of experience in venture capital focused on life science. Former Head of Life Science at SEB Venture Capital. Prior clinical and academic experience. Current assignments include CEO and board roles at Karolinska Development and Modus Therapeutics.
SVP & Chief Scientific Officer (born 1967). CSO since 2022. MSc in organic chemistry, PhD in biotechnology, Executive MBA. Over 20 years’ experience in discovery and development of small molecules and biologics at Astra Pain Control, Biovitrum, IMED AB and EMBL (Marie Curie Fellow). Former CEO of Umecrine Cognition (2012–2022).
Medical Director (born 1963). MD with postgraduate degree in Liver & Metabolic diseases. 35 years of experience in Clinical R&D at Abbott, Serono, Sigma‑tau, Alfasigma, Cosmo, Reithera and Epigen Therapeutics. Founder/board member of NIBIT Foundation. Co‑author of multiple publications.
Chief Operating Officer (born 1963). MSc in Pharmacy. Over 30 years’ clinical‑development experience in global and SME pharma. Former COO of InDex Pharmaceuticals, CEO of WntResearch. Board roles at Alzinova, LIF SME/IML and Pharmacists Without Borders.
Chief Financial Officer (born 1968). MSc in Economics. CFO since 2021. Previous CFO roles across industries; experience with multiple listings (e.g., AIK Fotboll, FundedByMe, Cedergrenska). Board roles include Livgrenadjärmässen Hotell, Hydra Consulting and HC Toll Control.